Stock Analysis · Cellebrite DI (CLBT)
Overview
Cellebrite DI (CLBT) is a software company best known for tools used in digital investigations. In practical terms, its products help authorized organizations collect and analyze information from devices and digital sources so they can support investigations and legal processes. The company’s customer base is heavily tied to the public sector (such as law enforcement and other government-related entities), and its offering typically sits at the intersection of security, compliance, and investigative workflows.
From an economic point of view, the company’s business model is mainly driven by software and services delivered to organizations that need ongoing access, updates, and support rather than one-time purchases only. This can make revenue more recurring over time compared with purely project-based work, although actual recurring share depends on how contracts are structured and renewed.
Based on how the company describes its operations in its SEC filings, its revenue is commonly discussed in categories such as software subscriptions/licenses and related services (implementation, support, training), but the exact mix and percentages can vary by period and contract type. If you want precise percentages, the most reliable place is the company’s latest annual report (Form 10-K) segment and revenue recognition notes.
Main sources of revenue typically include:
- Software subscriptions / licenses (access to investigation and analytics tools)
- Services (deployment, training, support, and professional services tied to the platform)
- Other / related revenue streams (as described in filings, depending on product packaging)
The company has also spent meaningfully on research and development over time, which is consistent with a strategy focused on keeping products effective as devices, encryption, operating systems, and data formats change.
Across the years shown, total revenue trends upward (from about $246M in 2021 to about $476M in 2025). Operating income is positive in 2021, 2022, 2024, and 2025, while 2023 shows an operating loss. Net income is more volatile than operating income, including a large net loss in 2024 despite positive operating income, which signals that non-operating items (notably interest expense in that year) had a major impact on bottom-line results.
Key Figures
| Metric | Value | Industry ⓘ |
|---|---|---|
| Date | Feb 16, 2026 | |
| Context | ||
| Sector | Technology | |
| Industry | Software - Infrastructure | |
| Market Cap ⓘ | $3.58B | |
| Beta ⓘ | 1.28 | |
| Fundamental | ||
| P/E Ratio ⓘ | 47.23 | 25.13 |
| Profit Margin ⓘ | 16.47% | 6.91% |
| Revenue Growth ⓘ | 18.10% | 15.25% |
| Debt to Equity ⓘ | 4.68% | 19.82% |
| PEG ⓘ | N/A | |
| Free Cash Flow ⓘ | $160.32M | |
Cellebrite DI’s market capitalization is about $3.58B, and the stock’s beta (~1.28) suggests it has tended to move more than the broader market on average. The latest P/E ratio (~47.2) is above the industry median (~25.1), while the company’s latest profit margin (~16.5%) is also above the industry median (~6.9%). Revenue growth year over year is about 18.1%, slightly above the industry median (~15.3%). Leverage appears low with debt-to-equity ~4.7% versus an industry median near 19.8%. Trailing twelve-month free cash flow is about $160M.
Growth (medium)
Cellebrite operates in a part of the software market linked to long-running trends: more digital activity, more data generated by mobile devices and cloud services, and increasing needs for organizations to investigate incidents and support legal or regulatory processes. Even without technical details, the direction is straightforward: as everyday life and business move further into apps, messaging, and cloud accounts, the volume and importance of digital evidence and digital investigation workflows tends to rise.
Strategically, the company’s emphasis on software capabilities and continued product development aligns with an environment where data sources change quickly (new phone models, operating system updates, new apps, stronger security features). The company’s ongoing R&D spending visible in its financial statements is consistent with maintaining product relevance in that shifting landscape.
The year-over-year revenue growth displayed is generally positive across the period shown, with growth often in the high single digits to mid-to-high 20% range, and most recently around 18%. That pattern indicates a business that has been expanding, though with variability quarter to quarter.
Free cash flow trends upward over the years shown (roughly $57M in mid-2021 to about $132M by early 2025, and about $160M most recently on a trailing basis in the table). For long-term business quality, sustained positive cash generation can matter because it can fund product development and operations without relying as heavily on new financing.
Potential catalysts (in a neutral, factual sense) typically relate to: broader adoption of digital investigation tools across agencies, expansion into additional geographies or customer types, new product releases that enlarge what the platform can handle, and multi-year contract wins or renewals that increase visibility. The exact timing and magnitude of these items depends on execution and procurement cycles.
Risks (high)
This article is for informational purposes only and does not constitute financial advice. Some content is AI-generated. See Disclaimer